Immunomodulation and Reduction of Thromboembolic Risk in Hospitalized COVID-19 Patients: Systematic Review and Meta-Analysis of Randomized Trials

Background: We aimed to investigate the potential beneficial effect of immunomodulation therapy on the thromboembolic risk in hospitalized COVID-19 patients. Methods: We searched PubMed and Scopus for randomized trials reporting the outcomes of venous thromboembolism (VTE), ischemic stroke or system...

Descripción completa

Detalles Bibliográficos
Autores principales: Sagris, Dimitrios, Florentin, Matilda, Tasoudis, Panagiotis, Korompoki, Eleni, Gatselis, Nikolaos, Giamarellos-Bourboulis, Evangelos J., Milionis, Haralampos, Douketis, James, Spyropoulos, Alex C., Dalekos, George, Ntaios, George
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8617689/
https://www.ncbi.nlm.nih.gov/pubmed/34830648
http://dx.doi.org/10.3390/jcm10225366

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8617689/
https://www.ncbi.nlm.nih.gov/pubmed/34830648
http://dx.doi.org/10.3390/jcm10225366

Ejemplares similares